| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 07/22/2009 | CN101486708A 4-nitro glyoxaline compound, preparation and use thereof |
| 07/22/2009 | CN101486707A 2-methyl-5-nitro glyoxaline compound, preparation and use thereof |
| 07/22/2009 | CN101486682A N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 07/22/2009 | CN101486679A 5HT2c receptor modulators |
| 07/22/2009 | CN101486678A 5HT2C receptor modulators |
| 07/22/2009 | CN101486677A 5HT2c receptor modulators |
| 07/22/2009 | CN101486675A 2- and 2,5-substituted phenylketoenols |
| 07/22/2009 | CN101485664A 5HT2c receptor modulators |
| 07/21/2009 | US7563910 Heterocyclic cannabinoid receptor antagonists |
| 07/21/2009 | US7563908 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRI |
| 07/21/2009 | US7563895 Quinoxaline compounds |
| 07/21/2009 | US7563894 e.g. [2-(4-Isopropyl-piperazin-1-yl)-benzooxazol-6-yl]-[5-(4-methoxy-phenyl)-pyrimidin-2-yl]-amine; C-kit kinase receptor or stem cell factor inhibitors; anticarcinogenic agents; veterinary medicine |
| 07/21/2009 | US7563893 3-Phenyl-cinnoline analogue and antitumor agent using the same |
| 07/21/2009 | US7563784 substituted 1,1,4-1l6-trioxo[1,2]thiazepan-4-ylamide-derived protease inhibitors which inhibit the likes of cathepsin K; treating osteoporosis, osteo- and rheumatoid arthritis and periodontal disease; inhibiting excessive cartilage or matrix degradation |
| 07/21/2009 | CA2495943C Indoles having anti-diabetic activity |
| 07/16/2009 | WO2009089042A1 Pyrazole pyrazine amine compounds as kinase inhibitors, compositions thereof and methods of treatment therewith |
| 07/16/2009 | WO2009088070A1 (heterocyclic methyl)azolylmethylcyclopentanol derivative and intermediate thereof, process for production of the derivative, and agricultural or horticultural preparation and protective agent for industrial material each comprising the derivative |
| 07/16/2009 | WO2009087649A1 Renin inhibitors |
| 07/16/2009 | WO2009087127A1 Modulators for amyloid beta |
| 07/16/2009 | WO2009067686A8 Sunitinib hemi-l-malate, polymorphs and preparation thereof, polymorphs of racemic sunitinib malate, compositins containing sunitinib base and malic acid and preparation thereof |
| 07/16/2009 | WO2009055335A3 Hcv protease inhibitors |
| 07/16/2009 | WO2009003999A3 Chemical compounds |
| 07/16/2009 | WO2008068171A9 Substituted pyrimidines and their use as jnk modulators |
| 07/16/2009 | US20090182152 Dimer Dianthranilate Bis-[N-Dodecylanilinophenylpyrazolone Carboxamide]Diazo]; for use in hot melt or phase change inks |
| 07/16/2009 | US20090182151 Method for making amphiphilic dendrimers |
| 07/16/2009 | US20090182140 Alicyclic Heterocyclic Compound |
| 07/16/2009 | US20090182114 Tetracarboxylic acid compound, polyimide thereof, and production method thereof |
| 07/16/2009 | US20090181994 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 07/16/2009 | US20090181993 Hiv inhibiting 5-heterocyclyl pyrimidines |
| 07/16/2009 | US20090181984 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use |
| 07/16/2009 | US20090181965 Modulators for amyloid beta |
| 07/16/2009 | US20090181964 Propane-1,3-Dione Derivative or Salt Thereof |
| 07/16/2009 | US20090181958 Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions |
| 07/16/2009 | US20090181953 Compound forms and uses thereof |
| 07/16/2009 | US20090181952 Compounds useful as alpha7 nicotinic acetylcholine receptor agonists |
| 07/16/2009 | US20090181949 1h-imidazole derivative having cb1, agonistic, cb1 partial agonistic or cb1 antagnistic activity |
| 07/16/2009 | US20090181943 Inhibitors of Histone Deacetylase |
| 07/16/2009 | US20090181939 Azetidinecarboxamide Derivatives And Their Use In The Treatment Of CB1 Receptor Mediated Disorders |
| 07/16/2009 | US20090181938 Aminopyrimidines useful as kinase inhibitors |
| 07/16/2009 | CA2703824A1 Modulators for amyloid beta |
| 07/15/2009 | EP2078011A1 Manufacture of rimcazole |
| 07/15/2009 | EP2078010A2 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/15/2009 | EP2078009A1 New fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone hsp 90 |
| 07/15/2009 | EP2078000A1 Benzoyl amino heterocyclyl compounds as glucokinase (glk) activators |
| 07/15/2009 | EP2077998A1 Phthalazine, aza- and diaza-phthalazine compounds and methods of use |
| 07/15/2009 | EP2077997A1 Pyridazine derivatives |
| 07/15/2009 | EP2077841A1 Novel substituted pyrimidines as cysteine protease inhibitors |
| 07/15/2009 | EP2005962A9 Therapeutic agent for inflammatory bowel disease |
| 07/15/2009 | EP1874304B1 Benzotriazole derivatives as cannabinoid receptor antagonists |
| 07/15/2009 | EP1426365B1 3-phenoxy-4-pyridazinol derivative and herbicide composition containing the same |
| 07/15/2009 | EP1379514B1 5-membered heterocycles, preparation and application thereof as medicaments |
| 07/15/2009 | CN101484444A Novel pyridazine compound and use thereof |
| 07/15/2009 | CN101484443A Potentiator of radiation therapy |
| 07/15/2009 | CN101481374A Method for removing trityl group of 1-trityl-5-(1,1'-biphenylyl-2 yl)-1H-tetrazole compound |
| 07/15/2009 | CN100513398C 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors |
| 07/14/2009 | US7560569 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity |
| 07/14/2009 | US7560551 Aurora kinase modulators and method of use |
| 07/14/2009 | US7560546 Tyrosine kinase inhibitors |
| 07/14/2009 | US7560483 Synthesizing 1- (acyloxy)-alkyl derivatives from 1-acyl-alkyl derivatives, which typically proceeds stereospecifically, in high yield, does not require the use of activated intermediates and/or toxic compounds and is readily amenable |
| 07/14/2009 | US7560481 Indoles are cannabinoid receptor ligands |
| 07/14/2009 | US7560480 Alkyl-containing 5-acylindolinones, the preparation thereof and their use as medicaments |
| 07/14/2009 | US7560471 5-{4-[1-(2-Ethoxyethyl)-1H-indol-3-yl]piperidin-1-ylmethyl}-2-methoxybenzoic acid; histamine H1 antagonists; bronchial dialtors; asthma; allergic rhinitis; conjunctivitis; dermatitis; urticaria; selective antiallergic effects so less side effect reduction and lower dosage |
| 07/14/2009 | US7560470 Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands |
| 07/14/2009 | US7560467 Indazolo-tetrahydropyrimidine-carboxamide derivative kinase inhibitors |
| 07/14/2009 | US7560466 N4-(2,2-Dimethyl-3-oxo-4H-5-pyrid[1,4]oxazin-6-yl)-N2-(3-chloro-4-methoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; signal transduction cascade inhibitor; Fc receptors for IgE (Fc epsilon RI) and IgG (Fc gamma RI) antagonist; autoimmune diseases, antiinflammatory agent; rheumatoid arthritis |
| 07/14/2009 | US7560462 Compounds useful for inhibiting CHK1 |
| 07/14/2009 | US7560461 Quinazoline derivatives as kinase inhibitors |
| 07/14/2009 | US7560460 2-[(4-Chlorophenyl)methyl]-1-(4- {2-[(cyclopropylmethyl)-(methylsulfonyl)amino]phenyl }-piperazinyl) -4-(2-(1,2,3,4-tetrahydroisoquinolyl))butane-1,4-dione; obesity/dietietics; melanocortin receptor angonists; prophylaxis/treatment of diseases involving activation of the melanocortin recepetors (MCR) |
| 07/14/2009 | US7560458 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 07/14/2009 | US7560456 Pesticidal pyridinecarboxamide derivatives |
| 07/14/2009 | US7560454 1-(4-(10,11-dihydro-5H-pyrrolo[2,1-c](1,4)benzodiazepine-10-ylcarbonyl)-2-methyl-benzylcarbamoyl)-4methoxy-L-proline-N,N-dimethylamide; vasopressin agonists particularly useful in the treatment of urogenital disorders central diabetes insipidus, nocturnal enuresis and nocturia; blood disorders |
| 07/10/2009 | WO2008083367A2 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/10/2009 | WO2008083357A1 Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/10/2009 | CA2710234A1 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/10/2009 | CA2710230A1 Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/09/2009 | WO2009086041A1 Herbicidal pyridazinone derivatives |
| 07/09/2009 | WO2009084695A1 2-aminoquinazoline derivative |
| 07/09/2009 | WO2009084614A1 Imidazole carbonyl compound |
| 07/09/2009 | WO2009084029A2 Improved process for the preparation of (2r,3s)-2-(2,4- difluqrophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl) butan-2-ol |
| 07/09/2009 | WO2009084028A2 Improved process for manufacturing anhydrous (e)-3-[2-butyl-1- {(4-carboxyphenyl) methyl}-1h-imidazole-5-yl]-(thiophen-2- ylmethyl)prop-2-enoic acid methane sulfonate |
| 07/09/2009 | WO2009083553A1 Azine compounds as glucokinase activators |
| 07/09/2009 | WO2009083076A1 2-benzylpyridazinone derivatives as met kinase inhibitors |
| 07/09/2009 | WO2009082845A1 N-{1-[3-(2-ethoxy-5-(4-ethylpiperazinyl)benzenesulfonyl)-4,5-dihydro-5-oxo-1,2,4-triazin-6-yl]ethyl}butyramide, the preparation method and use thereof |
| 07/09/2009 | WO2009057811A3 Heterocyclic compound and pharmaceutical composition thereof |
| 07/09/2009 | WO2008130368A3 Transcription factor modulating compounds and methods of use thereof |
| 07/09/2009 | WO2008039087A8 Indoline derivatives and uses thereof |
| 07/09/2009 | US20090176988 Preparation and Use of Magnesium Amides |
| 07/09/2009 | US20090176984 Isotopically Enriched N-Substituted Piperazine Acetic Acids And Methods For The Preparation Thereof |
| 07/09/2009 | US20090176981 Stereoisomerically Enriched 3-Aminocarbonyl Bicycloheptene Pyrimidinediamine Compounds And Their Uses |
| 07/09/2009 | US20090176973 Thrombopoietin mimetics |
| 07/09/2009 | US20090176859 Cathepsin cysteine protease inhibitors |
| 07/09/2009 | US20090176858 Hcv protease inhibitors and uses thereof |
| 07/09/2009 | US20090176849 Process for the preparation of 2-alkyl-1-((2'-substituted-biphenyl-4-yl) Methyl)-imidazole, dihydroimidazole or benzimidazloe derivatives |
| 07/09/2009 | US20090176840 Use of galr3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 07/09/2009 | US20090176806 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-(2-chlorophenyl)-4-[1-(3-hydroxypropyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2,5-dione, used for treating cardiovascular, skin, nervous system disorders and immunological disorders, diabetes, inflammatory diseases and cancer |
| 07/09/2009 | US20090176799 Phosphodiesterase 4 inhibitors |
| 07/09/2009 | US20090176798 New compounds III |
| 07/09/2009 | US20090176794 1h-indol-1-yl-urea compounds |
| 07/09/2009 | US20090176782 Inhibitors of tace |
| 07/09/2009 | US20090176781 Acetylenic Heteroaryl Compounds |